CA 123:198740 Sun et al. 1995. |
Abdallah Cherif, et al., "N-(5,5-Diacetoxypent-l-yl)doxorubicin: A New Intensely Potent Doxorubicin Analogue", J. Med. Chem., 35, 3208-3214, (1992). |
G. J. Fox, et al., "para-Bromination of Aromatic Amines: 4-Bromo-N,N-Dimethyl-3-(Trifluoromethyl)Aniline", Org. Syn., 55, 20-23, (1973). |
Barbara Gatto, et al., "Identification of Topoisomerase I as the Cyctotoxic Target of the Protoberberine Alkaloid Coralyne", Cancer Res., 56, 2795-2800, (1996). |
Masatomo Iwao, et al., "A Regiospecific Synthesis of Carbazones via Consecutive Palladium-Catalyzed Cross-coupling and Aryne-Mediated Cyclization", Heterocycles, 36, 1483-1488, (1993). |
J. S. Kim, et al., "Influence of steric factors on topoisomerase I inhibition and cytotoxicity of bisbenzimidazoles related to Hoechst 33342", Abstract 4, 86th annual meeting of the American Association for Cancer Research, Toronto, Ontario, Canada, 2689, (1995). |
J. S. Kim, et al., "Influence of steric factors on topoisomerase I inhibition and cytotoxicity of bisbenzimidazoles related to Hoechst 33342", Abstract 7, 3rd annual scientific retreat, Cancer Institute of New Jersey, Princeotn Marriot Forrestal Village, 28, (1995). |
J. S. Kim, et al., "Steric factors associated with the topoisomerase I inhibition and cytotoxicity of substituted bisbenzimidazoles", Abstract 10, American Assn of Pharmaceutical Scientists, Eastern Regional Meeting, 27, (1995). |
Jung Sun Kim, et al., "Structure-activity Relationships of Benzimidazoles and Related Heterocycles as Topoisomerase I Poisons", Biorganic & Med. Chem., 4, 621-630, (1996). |
Jung Sun Kim, et al., "Substituted 2,5'-Bi-1H-benzimidazoles: Topoisomerase I Inhibition and Cytotoxicity", J. Med. Chem., 39, 992-998, (1996). |
E. J. LaVoie, et al., "Structure-activity studies related to minor groove-binding ligands which inhibit mammalian DNA topoisomerase I", Abstract 1, 85th Annual Meeting of American Association for Cancer Research, Apr. 10-13, 1994, San Francisco, CA, 2699, (1994). |
Darshan Makhey, et al., "Coralyne and Related Compounds as Mammalian Topoisomerase I and Topoisomerase II Poisons", Bioorg. & Med. Chem. Lett., 4, 781-791, (1996). |
Darshan Makhey, et al., "Protoberberine Alkaloids and Related Compounds as Dual Inhibitors of Mammalian Topoisomerase I and II", Med. Chem. Res., 5, 1-12, (1994). |
Sanath K. Meegalla, et al., "Synthesis and Pharmacological Evaluation of Isoindolo �1,2-.beta.!quinazolinone and Isoindolo�2,1-.alpha.!benzimidazole Derivatives Related to the Antitumor Agent Batracylin", J. Med. Chem., 37, 3434-3439, (1994). |
Dan Peters, et al., "Synthesis of Various 5-Substituted Uracils", J. Heterocyclic Chem., 27, 2165-2173, (Nov. Dec. 19). |
Daniel S. Pilch, et al., "Biophysical Characterization of a Cytotoxic, Topoisomerase I Poison", Abstract 8, 3rd annual Scientific Retreat, Cancer Institute of New Jersey, 3, (1995). |
J. R. Piper, et al., "Synthesis and Antifolate Activity of 5-Methyl-5,10-dideaza Analogues of Aminopterin and Folic Acid and an Alternative Synthesis of 5,10-Dideazatetrahydrofolic Acid, a Potent Inhibitor of Glycinamide Ribonucleotide Formyltransferase", J. Med. Chem., 31, 2164-2169, (1988). |
B. A. Porai-Koshits, et al., "Imidazole derivatives Synthesis of some polybenzimidazoles", J. GEn. Chem. USSR, 23 as related in Chemical Abstracts, vol. 48, Nov. 10, 1954, Col. 12740, 873-9, (1953). |
B. A. Porai-Koshits, et al., "Imidazole derivatives. Synthesis of some polybenzimidazoles", Zhur. Obshchei Khim, 23, as related from Chemical Abstracts, vol. 48, Apr. 25, 1954, Col. 4523, 835-41, (1953). |
Malvinder P. Singh, et al., "Synthesis and Sequence-Specific DNA Binding of a Topoisomerase Inhibitory Analog of Hoechst 33258 Designed for Altered Base and Sequence Recognition", Chem. Res. Toxicol., 5, 597-607, (1992). |
Bathini Yadagiri, et al., "Convenient Routes to Substituted Benzimidazoles and Imidazolo�4,5-.beta.! Pyridines Using Nitrobenzene as Oxidant", Synthetic Communications, 20(7), 955-963, (1990). |
Allan Y. Chen et al., "DNA Topoisomerases: Essential Enzymes and Lethal Targets," Annu. Rev. Pharmacol. Toxicol., 34, 191-218 (1994). |
Allan Y. Chen et al., "DNA minor groove-binding ligands: A different class of mammalian DNA topoisomerase I inhibitors," Proc. Natl. Acad. Sci., USA, 90, 8131-8135 (Sep. 1993). |
Allan Y. Chen et al., "A New Mammalian DNA Topoisomerase I Poison Hoechst 33342: Cytoxicity and Drug Resistance in Human Cell Cultures," Cancer Research, 53, 1332-1337 (Mar. 15, 1993). |
Peter D'Arpa et al., "Topoisomerase-targeting antitumor drugs," Biochimica et Biophysica Acta, 989, 163-177 (1989). |
Robert C. Gallo et al., "Studies on the Antitumor Activity, Mechanism of Action, and Cell Cycle Effects of Camptothecin," Journal of the National Cancer Institute, 46, 789-795 (Apr., 1971). |
Beppino C. Giovanella et al., "Complete Growth Inhibition of Human Cancer Xenografts in Nude Mice by Treatment with 20-(S)-Camptothecin," Cancer Research, 51, 3052-3055 (Jun. 1, 1991). |